mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for MRPL20
Gene summary
Basic gene Info.Gene symbolMRPL20
Gene namemitochondrial ribosomal protein L20
SynonymsL20mt|MRP-L20
CytomapUCSC genome browser: 1p36.3-p36.2
Type of geneprotein-coding
RefGenesNM_017971.3,
Description39S ribosomal protein L20, mitochondrial
Modification date20141207
dbXrefs MIM : 611833
HGNC : HGNC
Ensembl : ENSG00000242485
HPRD : 14746
Vega : OTTHUMG00000002916
ProteinUniProt: Q9BYC9
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_MRPL20
BioGPS: 55052
PathwayNCI Pathway Interaction Database: MRPL20
KEGG: MRPL20
REACTOME: MRPL20
Pathway Commons: MRPL20
ContextiHOP: MRPL20
ligand binding site mutation search in PubMed: MRPL20
UCL Cancer Institute: MRPL20
Assigned class in mutLBSgeneDBC: This gene just belongs to mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for MRPL20

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
F128E126KCOAD1
V43,L41A42VHNSC1
R32R32LLUAD1
G88G88WPRAD1
R40R40KSKCM1
R37R37SSKCM1
F128F128CUCEC1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for MRPL20
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
R40R40K-1.0236014
R37R37S-0.95919689
F128F128C-0.59481251
V43A42V-0.46499376
L41A42V-0.46499376
F128E126K-0.36487484
G88G88W-0.11885308
R32R32L-0.023830347
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for MRPL20 from PDB

Top
Differential gene expression and gene-gene network for MRPL20
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of MRPL20 and the right PPI network was created from samples without mutations in the LBS of MRPL20. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for MRPL20
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for MRPL20
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of MRPL20 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
NUCNucleic Acids3j7yRR32 R37 R40 L41 V43 G88 F128


Top
Conservation information for LBS of MRPL20
Multiple alignments for Q9BYC9 in multiple species
LBSAA sequence# speciesSpecies
A49RTVIRAFVKCT1Homo sapiens
A49RAVTRAFVRCT1Bos taurus
A49RAVTRAFVKCT1Mus musculus
A56VKCTKARYLKK1Homo sapiens
A56VRCTRARSLKK1Bos taurus
A56VKCTKARRLKK1Mus musculus
C38GRKNRCYRLAV3Homo sapiens, Bos taurus, Mus musculus
C53RAFVKCTKARY1Homo sapiens
C53RAFVRCTRARS1Bos taurus
C53RAFVKCTKARR1Mus musculus
F128RRHEGFAAALG1Homo sapiens
F128RREEGFVAALG1Bos taurus
F128RQQEGFAAALG1Mus musculus
F31KHARHFRGRKN2Homo sapiens, Bos taurus
F31KHAQHFRGRKN1Mus musculus
G88YPALIGNLVKC1Homo sapiens
G88YPAFILNLIKC1Bos taurus
G88YPAFIVNLIKC1Mus musculus
H30LKHARHFRGRK2Homo sapiens, Bos taurus
H30LKHAQHFRGRK1Mus musculus
I47AVRTVIRAFVK1Homo sapiens
I47AVRAVTRAFVR1Bos taurus
I47AVRAVTRAFVK1Mus musculus
K100VELNRKVLADL2Homo sapiens, Bos taurus
K100VELNRKVLVDL1Mus musculus
K35HFRGRKNRCYR3Homo sapiens, Bos taurus, Mus musculus
K52IRAFVKCTKAR1Homo sapiens
K52TRAFVRCTRAR1Bos taurus
K52TRAFVKCTKAR1Mus musculus
K60KARYLKKKNMR1Homo sapiens
K60RARSLKKRHLR1Bos taurus
K60KARRLKKRNLR1Mus musculus
K61ARYLKKKNMRT1Homo sapiens
K61ARSLKKRHLRT1Bos taurus
K61ARRLKKRNLRT1Mus musculus
K62RYLKKKNMRTL1Homo sapiens
K62RSLKKRHLRTL1Bos taurus
K62RRLKKRNLRTL1Mus musculus
K82QEHGLKYPAFI2Bos taurus, Mus musculus
K82QEHGLKYPALI1Homo sapiens
L10TAQLWLRNRVT1Homo sapiens
L10SAPLWLRNRIT1Bos taurus
L10TTRLWLRNRLT1Mus musculus
L41NRCYRLAVRAV2Bos taurus, Mus musculus
L41NRCYRLAVRTV1Homo sapiens
L59TKARYLKKKNM1Homo sapiens
L59TRARSLKKRHL1Bos taurus
L59TKARRLKKRNL1Mus musculus
M64LKKKNMRTLWI1Homo sapiens
M64LKKRHLRTLWI1Bos taurus
M64LKKRNLRTLWI1Mus musculus
N12QLWLRNRVTDR1Homo sapiens
N12PLWLRNRITDR1Bos taurus
N12RLWLRNRLTDR1Mus musculus
N98CQVELNRKVLA2Homo sapiens, Bos taurus
N98CQVELNRKVLV1Mus musculus
P84HGLKYPALIGN1Homo sapiens
P84HGLKYPAFILN1Bos taurus
P84HGLKYPAFIVN1Mus musculus
R11AQLWLRNRVTD1Homo sapiens
R11APLWLRNRITD1Bos taurus
R11TRLWLRNRLTD1Mus musculus
R13LWLRNRVTDRY1Homo sapiens
R13LWLRNRITDRY1Bos taurus
R13LWLRNRLTDRY1Mus musculus
R17NRVTDRYFRIQ1Homo sapiens
R17NRITDRYWRVQ1Bos taurus
R17NRLTDRYWRVQ1Mus musculus
R20TDRYWRVQEVL2Bos taurus, Mus musculus
R20TDRYFRIQEVL1Homo sapiens
R32HARHFRGRKNR2Homo sapiens, Bos taurus
R32HAQHFRGRKNR1Mus musculus
R34RHFRGRKNRCY2Homo sapiens, Bos taurus
R34QHFRGRKNRCY1Mus musculus
R37RGRKNRCYRLA3Homo sapiens, Bos taurus, Mus musculus
R40KNRCYRLAVRA2Bos taurus, Mus musculus
R40KNRCYRLAVRT1Homo sapiens
R44YRLAVRAVTRA2Bos taurus, Mus musculus
R44YRLAVRTVIRA1Homo sapiens
R48VRTVIRAFVKC1Homo sapiens
R48VRAVTRAFVRC1Bos taurus
R48VRAVTRAFVKC1Mus musculus
R57KCTKARYLKKK1Homo sapiens
R57RCTRARSLKKR1Bos taurus
R57KCTKARRLKKR1Mus musculus
R65KKKNMRTLWIN1Homo sapiens
R65KKRHLRTLWIN1Bos taurus
R65KKRNLRTLWIN1Mus musculus
R99QVELNRKVLAD2Homo sapiens, Bos taurus
R99QVELNRKVLVD1Mus musculus
T15LRNRVTDRYFR1Homo sapiens
T15LRNRITDRYWR1Bos taurus
T15LRNRLTDRYWR1Mus musculus
V14WLRNRVTDRYF1Homo sapiens
V14WLRNRITDRYW1Bos taurus
V14WLRNRLTDRYW1Mus musculus
V43CYRLAVRAVTR2Bos taurus, Mus musculus
V43CYRLAVRTVIR1Homo sapiens
W68NMRTLWINRIT1Homo sapiens
W68HLRTLWINRIT1Bos taurus
W68NLRTLWINRIT1Mus musculus
Y39RKNRCYRLAVR3Homo sapiens, Bos taurus, Mus musculus
Y58CTKARYLKKKN1Homo sapiens
Y58CTRARSLKKRH1Bos taurus
Y58CTKARRLKKRN1Mus musculus
Y83EHGLKYPALIG1Homo sapiens
Y83EHGLKYPAFIL1Bos taurus
Y83EHGLKYPAFIV1Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas